Dysregulated VLDL-TAG (very-low-density lipoprotein triacylglycerol) metabolism in obesity may account for hypertriacylglycerolaemia and increased cardiovascular disease. ω-3 FAEEs (omega-3 fatty acid ethyl esters) decrease plasma TAG and VLDL concentrations, but the mechanisms are not fully understood. In the present study, we carried out a 6-week randomized, placebo-controlled study to examine the effect of high-dose ω-3 FAEE supplementation (3.2 g/day) on the metabolism of VLDL-TAG in obese men using intravenous administration of d5-glycerol. We also explored the relationship of VLDL-TAG kinetics with the metabolism of VLDL-apo (apolipoprotein) B-100 and HDL (high-density lipoprotein)-apoA-I. VLDL-TAG isotopic enrichment was measured using gas chromatography-mass spectrometry. Kinetic parameters were derived using a multicompartmental model. Compared with placebo, ω-3 FAEE supplementation significantly lowered plasma concentrations of total (−14%, P<0.05) and VLDL-TAG (−32%, P<0.05), as well as hepatic secretion of VLDL-TAG (−32%, P<0.03). The FCR (fractional catabolic rate) of VLDL-TAG was not altered by ω-3 FAEEs. There was a significant association between the change in secretion rates of VLDL-TAG and VLDL-apoB-100 (r=0.706, P<0.05). However, the change in VLDL-TAG secretion rate was not associated with change in HDL-apoA-I FCR (r=0.139, P>0.05). Our results suggest that the TAG-lowering effect of ω-3 FAEEs is associated with the decreased VLDL-TAG secretion rate and hence lower plasma VLDL-TAG concentration in obesity. The changes in VLDL-TAG and apoB-100 kinetics are closely coupled.
Skip Nav Destination
Article navigation
Research Article|
March 13 2013
Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men
Annette T. Y. Wong;
Annette T. Y. Wong
*School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia
Search for other works by this author on:
Dick C. Chan;
Dick C. Chan
*School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia
Search for other works by this author on:
Esther M. M. Ooi;
Esther M. M. Ooi
*School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia
Search for other works by this author on:
Theodore W. K. Ng;
Theodore W. K. Ng
*School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia
Search for other works by this author on:
Gerald F. Watts;
Gerald F. Watts
*School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia
Search for other works by this author on:
P. Hugh R. Barrett
*School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia
†Faculty of Engineering, Computing and Mathematics, University of Western Australia, Perth, WA, Australia
Correspondence: Professor Hugh Barrett (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
October 29 2012
Revision Received:
January 17 2013
Accepted:
January 28 2013
Accepted Manuscript online:
January 28 2013
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2013 Biochemical Society
2013
Clin Sci (Lond) (2013) 125 (1): 45–51.
Article history
Received:
October 29 2012
Revision Received:
January 17 2013
Accepted:
January 28 2013
Accepted Manuscript online:
January 28 2013
Citation
Annette T. Y. Wong, Dick C. Chan, Esther M. M. Ooi, Theodore W. K. Ng, Gerald F. Watts, P. Hugh R. Barrett; Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men. Clin Sci (Lond) 1 July 2013; 125 (1): 45–51. doi: https://doi.org/10.1042/CS20120587
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |